Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Mitchell

Showing results (181-190 of 237) with videos related to

Pageof 24
Sort By:
Journal of Biomedical Science|November 27, 2007
DNA (cytosine-5)-methyltransferase 1 as a mediator of mutant p53-determined p16(ink4A) down-regulationZhanjun Guo, Mong-Hsun Tsai, Yih-Horng Shiao, et al.
JCI Insight|March 9, 2022
Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunityYouji Hong, Yvette Robbins, Xinping Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2021
Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor VasculogenesisSarwat Naz, Andrew J Leiker, Rajani Choudhuri, et al.
Translational Oncology|August 3, 2013
HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell CarcinomaJay A Friedman, Stephanie C Wise, Michael Hu, et al.
International Journal of Biomedical Imaging|August 13, 2009
Reconstruction for time-domain in vivo EPR 3D multigradient oximetric imaging--a parallel processing perspectiveChristopher D Dharmaraj, Kishan Thadikonda, Anthony R Fletcher, et al.
Cancer Letters|July 29, 2014
Systemic DNA damage accumulation under in vivo tumor growth can be inhibited by the antioxidant TempolAlexandros G Georgakilas, Christophe E Redon, Nicholas F Ferguson, et al.
British Journal of Pharmacology|June 11, 2011
Nitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cellsWilmarie Flores-Santana, Terry Moody, Weibin Chen, et al.
Cancer Research|October 11, 2018
A Multimodal Molecular Imaging Study Evaluates Pharmacological Alteration of the Tumor Microenvironment to Improve Radiation ResponseYoichi Takakusagi, Sarwat Naz, Kaori Takakusagi, et al.
American Journal of Physiology. Renal Physiology|September 12, 2025
Electron paramagnetic resonance imaging to detect acute kidney injuryShun Kishimoto, Kazumasa Horie, Nallathamby Devasahayam, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2010
Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriersArjan Vissink, James B Mitchell, Bruce J Baum, et al.
Pageof 24

Showing results (181-190 of 237) with videos related to

Sort By:
Pageof 24
Journal of Biomedical Science|November 27, 2007
DNA (cytosine-5)-methyltransferase 1 as a mediator of mutant p53-determined p16(ink4A) down-regulationZhanjun Guo, Mong-Hsun Tsai, Yih-Horng Shiao, et al.
JCI Insight|March 9, 2022
Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunityYouji Hong, Yvette Robbins, Xinping Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2021
Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor VasculogenesisSarwat Naz, Andrew J Leiker, Rajani Choudhuri, et al.
Translational Oncology|August 3, 2013
HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell CarcinomaJay A Friedman, Stephanie C Wise, Michael Hu, et al.
International Journal of Biomedical Imaging|August 13, 2009
Reconstruction for time-domain in vivo EPR 3D multigradient oximetric imaging--a parallel processing perspectiveChristopher D Dharmaraj, Kishan Thadikonda, Anthony R Fletcher, et al.
Cancer Letters|July 29, 2014
Systemic DNA damage accumulation under in vivo tumor growth can be inhibited by the antioxidant TempolAlexandros G Georgakilas, Christophe E Redon, Nicholas F Ferguson, et al.
British Journal of Pharmacology|June 11, 2011
Nitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cellsWilmarie Flores-Santana, Terry Moody, Weibin Chen, et al.
Cancer Research|October 11, 2018
A Multimodal Molecular Imaging Study Evaluates Pharmacological Alteration of the Tumor Microenvironment to Improve Radiation ResponseYoichi Takakusagi, Sarwat Naz, Kaori Takakusagi, et al.
American Journal of Physiology. Renal Physiology|September 12, 2025
Electron paramagnetic resonance imaging to detect acute kidney injuryShun Kishimoto, Kazumasa Horie, Nallathamby Devasahayam, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2010
Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriersArjan Vissink, James B Mitchell, Bruce J Baum, et al.
Pageof 24